Classical chemotherapy for metastatic melanoma.

Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis. J Carcinog (2004) 3.02

Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells. Clin Exp Metastasis (2002) 1.36

Non-toxic melanoma therapy by a novel tubulin-binding agent. Int J Cancer (2010) 1.01

A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin. Neoplasia (2009) 0.91

Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma. Expert Opin Ther Targets (2010) 0.89

Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology Group. J Cancer Res Clin Oncol (2007) 0.78

Skewed Differentiation of Circulating Vγ9Vδ2 T Lymphocytes in Melanoma and Impact on Clinical Outcome. PLoS One (2016) 0.78

Dinitrophenyl hapten with laser immunotherapy for advanced malignant melanoma: A clinical study. Oncol Lett (2016) 0.75

Proliferating dendritic cell progenitors in human blood. J Exp Med (1994) 7.67

High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med (1996) 5.29

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods (1996) 4.87

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med (1999) 4.20

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods (1999) 3.09

Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity (2000) 2.93

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Ann Oncol (2006) 2.88

Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation. J Exp Med (1990) 2.82

Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells. J Exp Med (1990) 2.21

Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc Natl Acad Sci U S A (1997) 1.85

Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma. J Pathol (1999) 1.68

Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J Infect Dis (1996) 1.44

Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells. J Immunol (2000) 1.32

Human decidua contains potent immunostimulatory CD83(+) dendritic cells. Am J Pathol (2000) 1.24

Cytokine gene expression in murine epidermal cell suspensions: interleukin 1 beta and macrophage inflammatory protein 1 alpha are selectively expressed in Langerhans cells but are differentially regulated in culture. J Exp Med (1992) 1.18

Listeria monocytogenes-infected human dendritic cells: uptake and host cell response. Infect Immun (2000) 1.14

Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood (2000) 1.13

Dendritic cells: multi-lineal and multi-functional. Immunol Today (2000) 1.10

A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles. J Gen Virol (2000) 1.10

Migration of dendritic cells within 3-D collagen lattices is dependent on tissue origin, state of maturation, and matrix structure and is maintained by proinflammatory cytokines. J Leukoc Biol (2000) 1.08

Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer. Gene Ther (2009) 1.05

Migration of dendritic cells in 3D-collagen lattices. Visualisation of dynamic interactions with the substratum and the distribution of surface structures via a novel confocal reflection imaging technique. Adv Exp Med Biol (1997) 1.05

Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2. Br J Cancer (2002) 1.03

Maturation of dendritic cells leads to up-regulation of cellular FLICE-inhibitory protein and concomitant down-regulation of death ligand-mediated apoptosis. Blood (2000) 1.01

[Malignant melanoma of the lacrimal sac]. Ophthalmologe (2008) 0.95

MHC class II and CD40 play opposing roles in dendritic cell survival. Eur J Immunol (2000) 0.95

Antigen processing in populations of mature murine dendritic cells is caused by subsets of incompletely matured cells. J Immunol (1995) 0.94

Antibodies against listerial protein 60 act as an opsonin for phagocytosis of Listeria monocytogenes by human dendritic cells. Infect Immun (2001) 0.94

Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination: cessation of CTL responses is associated with disease progression. Int J Cancer (2001) 0.93

CD40-ligated dendritic cells effectively expand melanoma-specific CD8+ CTLs and CD4+ IFN-gamma-producing T cells from tumor-infiltrating lymphocytes. J Immunol (2000) 0.92

Murine epidermal Langerhans cells as a model to study tissue dendritic cells. Adv Exp Med Biol (1993) 0.92

Interaction of Neisseria meningitidis with human dendritic cells. Infect Immun (2001) 0.91

Functions of myeloid and lymphoid dendritic cells. Immunol Lett (2000) 0.87

Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell development. Cell Death Differ (2000) 0.86

Effective enrichment of murine epidermal Langerhans cells by a modified(mismatched) panning technique. J Invest Dermatol (1992) 0.86

Leucocyte activation in erythema nodosum. Clin Exp Dermatol (1999) 0.85

Longitudinal analysis of MART-1/HLA-A2-reactive T cells over the course of melanoma progression. Scand J Immunol (2003) 0.83

Sequential interferon-alpha2b, interleukin-2 and fotemustine for patients with metastatic melanoma. Melanoma Res (2000) 0.83

Dendritic cell production of cytokines and responses to cytokines. Int Rev Immunol (1990) 0.83

[Immunochemotherapy of malignant melanoma. Epifocal administration of dinitrochlorobenzene (DNCB) combined with systemic chemotherapy with dacarbazine (DTIC)]. Hautarzt (1998) 0.82

Acute generalized exanthematous pustulosis following oral nystatin therapy: a report of three cases. Br J Dermatol (1997) 0.82

Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2-transfected cancer cells: outcome of a phase I study. Hum Gene Ther (1999) 0.80

Dendritic cell activation by danger and antigen-specific T-cell signalling. Exp Dermatol (2000) 0.80

[Immunochemotherapy of metastatic uveal melanoma with interferon alfa-2b, interleukin-2 and fotemustine. Case reports and review of the literature]. Hautarzt (1998) 0.79

Fotemustine given simultaneously with total brain irradiation in multiple brain metastases of malignant melanoma: report on a pilot study. Melanoma Res (1996) 0.79

Recurrent herpes simplex virus-induced erythema multiforme: different HLA-DQB1 alleles associate with severe mucous membrane versus skin attacks. Scand J Immunol (1998) 0.79

TNF alpha interrupts antigen-presenting function of Langerhans cells by two mechanisms: loss of immunogenic peptides and impairment of antigen-independent T cell clustering. Adv Exp Med Biol (1995) 0.78

Predominant expression of Fas (CD95) ligand in metastatic melanoma revealed by longitudinal analysis. J Invest Dermatol (1999) 0.78

Isolation, enrichment, and culture of murine epidermal langerhans cells. Methods Mol Med (2001) 0.78

Severe bullous drug reactions treated successfully with cyclophosphamide. Br J Dermatol (1998) 0.77

[Nevus of Ota and choroid melanoma]. Hautarzt (2001) 0.75

Phospholipase A2 is secreted by murine keratinocytes after stimulation with IL-1 alpha and TNF-alpha. Arch Dermatol Res (1996) 0.75

Effective combined immunochemotherapy with dinitrochlorobenzene and fotemustine in skin and brain metastases of melanoma. Melanoma Res (1998) 0.75

[Radiologic search for tumors in skin changes. Paraneoplastic syndromes and hereditary diseases with increased risk of tumors]. Radiologe (1988) 0.75

Fluorescein-guided confocal laser endomicroscopy for the detection of ipilimumab-induced colitis. Endoscopy (2012) 0.75

Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene. J Mol Med (Berl) (1997) 0.75